Vietnamese Journal of Neurology

Article detail

Article detail description

Home
Tổng quan Issue: Số 32 - 2022 Rối loạn vận động

Progressive Supranuclear Palsy: An Overview

Published: March 18, 2022
Lượt đọc: 0

Abstract

Progressive supranuclear palsy (PSP) is the most common neurodegenerative disorder among the atypical parkinsonian syndromes. The characteristic clinical features of PSP include vertical supranuclear gaze palsy, postural instability with recurrent unexplained falls, bradykinesia, and cognitive impairment. Neuropathologically, PSP is characterized by the abnormal accumulation of tau protein and is classified as a primary tauopathy.

Keywords
Progressive supranuclear palsy Atypical parkinsonism Tau protein Movement disorders

References

1.
Steele J.C., Richardson J.C., Olszewski J. (1964). Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. *Archives of Neurology*. 1964; 10(4):333–359.
2.
Schrag A., Ben-Shlomo Y., Quinn N.P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. *Lancet*. 1999; 354(9192):1771–1775.
3.
Respondek G., Stamelou M., Kurz C., et al. (2014). The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. *Movement Disorders*. 2014; 29(14):1758–1766.
4.
Pittman A.M., Myers A.J., Duckworth J., et al. (2004). The structure of the tau haplotype in controls and in progressive supranuclear palsy. *Human Molecular Genetics*. 2004; 13(12):1267–1274.
5.
Kovacs G.G. (2015). Invited review: Neuropathology of tauopathies: principles and practice. *Neuropathology and Applied Neurobiology*. 2015; 41(1):3–23.
6.
Agarwal S., Gilbert R. (2022). Progressive Supranuclear Palsy. *StatPearls*. StatPearls Publishing, Treasure Island (FL).
7.
Massey L.A., Micallef C., Paviour D.C., et al. (2012). Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. *Movement Disorders*. 2012; 27(14):1754–1762.
8.
Saeed U., Lang A.E., Masellis M. (2020). Neuroimaging Advances in Parkinson’s Disease and Atypical Parkinsonian Syndromes. *Frontiers in Neurology*. 2020; 11:572976.
9.
Giagkou N., Höglinger G.U., Stamelou M. (2019). Progressive supranuclear palsy. *International Review of Neurobiology*. 2019; 149:49–86.
10.
Rojas J.C., Bang J., Lobach I.V., et al. (2018). CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. *Neurology*. 2018; 90(4):e273–e281.
11.
Höglinger G.U., Respondek G., Stamelou M., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. *Movement Disorders*. 2017; 32(6):853–864.

Authors

Lê Thị Ngọc Bệnh viện Lão khoa Trung ương Nguyễn Thanh Bình Đại học Y Hà Nội
Progressive Supranuclear Palsy: An Overview

Files

PDF

Trích dẫn

APA

Định dạng

Tải trích dẫn

Article Views0
Document Views0
Downloads0
Section Tổng quan
Issue Số 32 - 2022
Category Rối loạn vận động
Pages 78-86
Copyright Holder 2022 Tạp chí thần kinh học Việt Nam

Related articles section label

Related articles

Related articles category hint

More articles